BioCryst製藥 | 4:持股變動聲明-高管 Thackray Helen M.
04/02 16:27 (美東)
BioCryst製藥 | 4:持股變動聲明-董事 MILANO VINCENT
03/04 17:51 (美東)
BioCryst製藥 | 4:持股變動聲明-董事 HEGGIE THERESA
03/04 16:36 (美東)
BioCryst製藥 | SC 13G/A:超過5%持股股東披露文件(修正)-Felix J. Baker(4.98%),Julian C. Baker(4.98%)等
02/14 17:47 (美東)
BioCryst製藥 | SC 13G:超過5%持股股東披露文件-Avoro Capital Advisors LLC(6.4%),Behzad Aghazadeh(6.4%)
02/14 09:07 (美東)
BioCryst製藥 | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(8.67%)
02/13 18:08 (美東)
BioCryst製藥 | SC 13G/A:超過5%持股股東披露文件(修正)-BlackRock, Inc.(9.1%)
01/24 17:32 (美東)
BioCryst製藥 | SC 13G/A:超過5%持股股東披露文件(修正)-STATE STREET CORPORATION(6.24%)
01/24 13:10 (美東)
BioCryst製藥 | 4:持股變動聲明-高管 Stonehouse Jon P
01/04 00:00 (美東)
BioCryst製藥 | 4:持股變動聲明-高管 Thackray Helen M.
2023/12/20 16:42 (美東)
BioCryst製藥 | 4:持股變動聲明-高管 Stonehouse Jon P
2023/12/20 16:40 (美東)
BioCryst製藥 | 4:持股變動聲明-首席商務官 Gayer Charles K
2023/12/20 16:38 (美東)
BioCryst製藥 | 4:持股變動聲明-首席財務官 Doyle Anthony
2023/12/20 16:35 (美東)
BioCryst製藥 | 4:持股變動聲明-首席法務官 Barnes Alane P
2023/12/20 16:33 (美東)
BioCryst製藥 | 4:持股變動聲明-高管 Thackray Helen M.
2023/12/18 16:47 (美東)
BioCryst製藥 | 4:持股變動聲明-高管 Stonehouse Jon P
2023/12/18 16:43 (美東)
BioCryst製藥 | 4:持股變動聲明-首席商務官 Gayer Charles K
2023/12/18 16:40 (美東)
BioCryst製藥 | 4:持股變動聲明-首席財務官 Doyle Anthony
2023/12/18 16:37 (美東)
BioCryst製藥 | 4:持股變動聲明-首席法務官 Barnes Alane P
2023/12/18 16:34 (美東)
BioCryst製藥 | 4:持股變動聲明-董事 MILANO VINCENT
2023/12/01 16:42 (美東)
暫無數據
暫無數據